Walden Group Healthcare M&A Blog

Steris plc Acquires Cantel Medical for $4.6b

1/18/2021
Steris plc (NYSE: STE), a $3.0b Ireland-based provider of sterile processing services, endoscope repair, cleaning chemistries and assurance products, announced plans to acquire Cantel Medical (NYSE:CMD), a provider of infection prevention products and services focused on endoscopy and dental customers for $4.6b. Cantel’s largest business, its...
Read More
Collagen Matrix Acquires Sunstar’s Degradable Solutions Product Line

1/4/2021
Collagen Matrix, a developer of xenograft-derived tissue and bone repair/regeneration products and portfolio company of private equity firm Linden Capital, announced that it has acquired Sunstar’s Switzerland-based Degradable Solutions Division. The deal adds the GUIDOR® branded line of resorbable synthetic medical implants, which includes...
Read More
Philips to Acquire BioTelemetry for $2.8b

12/21/2020
Netherlands-based Philips (NYSE:PHG) announced it is buying BioTelemetry (Nasdaq: BEAT) to extend its hospital-based remote patient monitoring reach to outpatient settings. BioTelemetry’s offerings include wearable heart monitors (i.e. a mobile cardiac outpatient telemetry patch and extended Holter monitor) that wirelessly detect and transmit...
Read More
Zimmer Biomet Acquires Sternal Closure Company A&E Medical from Vance Street Capital

12/7/2020
Zimmer Biomet, a $8.0b maker of musculoskeletal products for spine, craniomaxillofacial, thoracic and dental applications, has acquired A&E Medical Corporation, a manufacturer of sternal closure devices. The deal adds a portfolio of sternal sutures, cable systems, and rigid fixation products and complementary single-use temporary pacing...
Read More
The Walden Group Releases Q3 2020 Strategic Healthcare M&A Report

11/30/2020
The Walden Group is pleased to provide access to its Q3 2020 Strategic Healthcare M&A Report, which includes: Q3 healthcare industry landscape and experience of key Medtech companies. Notable M&A deals announced since March 2020. Stock market performance of key Medtech companies. Detailed deal-by-deal analysis of more...
Read More